TransMedics to Present at Upcoming March Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TransMedics Group, a leader in organ transplant technology, announced participation in two major investor conferences. The company will engage in a fireside chat at the Cowen 43rd Annual Healthcare Conference on March 6, 2023, at 9:10 a.m. EST, and will present virtually at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 12:00 p.m. EST. Both events will feature a live and archived webcast accessible through the TransMedics investor website. TransMedics focuses on innovative solutions to enhance organ transplant therapies for patients facing end-stage organ failure.
Details
News Market Reaction – TMDX
The recorded move for TMDX in the trading session of this news was -0.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Cowen 43rd Annual Healthcare Conference in Boston on Monday, March 6, 2023, at 9:10 a.m. EST and to present virtually at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 12:00 p.m. EST.
Event: Cowen 43rd Annual Healthcare Conference
Date: Monday, March 6, 2023
Time: 9:10 a.m. EST
Event: Oppenheimer 33rd Annual Healthcare Conference
Date: Monday, March 13, 2022
Time: 12:00 p.m. EST
A live and archived webcast of the presentations will be available on the “Investors” section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.